Villamonte, Trinidad .
HRN: 26-72-42 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/21/2025
LEVOFLOXACIN 500MG (TAB)
02/21/2025
02/28/2025
PO
500mg
OD
Breast Mass, Right
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes